Type-2-Diabetes - Aliskiren promises high nephroprotective potential

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A17 / A18
页数:2
相关论文
共 50 条
  • [1] Additional use of Aliskiren for Type-2-Diabetes; Cardiovascular and renal Events in the ALTITUDE-Study
    Jecht, M.
    [J]. DIABETOLOGE, 2013, 9 (01): : 57 - 58
  • [2] Gene Type-2-Diabetes A Portal helps to understand Type-2-Diabetes better
    不详
    [J]. DIABETES STOFFWECHSEL UND HERZ, 2016, 25 (04): : 258 - 258
  • [3] How high is the Mortality Risk for Type-2-Diabetes?
    不详
    [J]. NEPHROLOGE, 2016, 11 (06): : 380 - 380
  • [4] Prevention of the Type-2-Diabetes
    Stefan, N.
    Fritsche, A.
    Haering, H. -U.
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2008, 3 (04) : R57 - R68
  • [5] Therapy of Type-2-Diabetes
    Landgraf, Ruediger
    Aberle, Jens
    Birkenfeld, Andreas L.
    Gallwitz, Baptist
    Kellerer, Monika
    Klein, Harald
    Mueller-Wieland, Dirk
    Nauck, Michael A.
    Reuter, Hans-Martin
    Siegel, Erhard
    [J]. DIABETOLOGE, 2021, 17 (04): : 422 - 447
  • [6] Therapy of Type-2-Diabetes
    Landgraf, Ruediger
    Kellerer, Monika
    Fach, Eva-Maria
    Gallwitz, Baptist
    Hamann, Andreas
    Joost, Hans-Georg
    Klein, Harald
    Mueller-Wieland, Dirk
    Nauck, Michael A.
    Reuter, Hans-Martin
    Schreiber, Stephan
    Siegel, Erhard
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2017, 12 : S141 - S156
  • [7] Type-2-Diabetes in Adolescence
    Pavlicek, V.
    [J]. DIABETOLOGE, 2012, 8 (05): : 412 - 413
  • [8] The nephroprotective Effect of Telmisartan and Losartan in Patients with Type-2-Diabetes and arterial Hypertension under the Influence of the glycemic Control
    Hofler-Speckner, Simone
    [J]. JOURNAL FUR KARDIOLOGIE, 2007, 14 (9-10): : 302 - 302
  • [9] Amyloid Formation in Type-2-Diabetes
    不详
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (08) : 442 - 442
  • [10] Early detection of Type-2-Diabetes
    不详
    [J]. DIABETES STOFFWECHSEL UND HERZ, 2019, 28 (03): : 156 - 156